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Small proteoglycans h.ave been sh.own to act as 
receptors for matrix molecules or growth factors 
and to influence the attachment and the migration 
of cells. We therefore report here on the immuno-
cytochemical expression of three small proteogly-
cans, i.e., decorin, biglycan, and the recently de-
scribed PG-100, in normal human skin and in basal 
cell carcinoma. In normal human skin, staining for 
decorin revealed expression throughout the d ··mis 
with an increased signal in the papillary dermis, 
whereas no expression was observed in the epider-
mis. Biglycan and PG-100 were mainly detected in 
the epidermis, with biglycan being expressed only 
in supra basal layers. In addition, biglycan could be 
detected in a narrow zone below the basement 
membrane. In tissue specimens obtained from 12 
basal cell carcinomas, the expression of biglycan 
T he extracellular matrix participates in the regulation of cell proliferation , migra tion , and diffe rentiation [1] ., Thus, extracellular matrLx molecules have an important ro le in the development and maintenance of normal tissue architecture, as well as in the 
formation of benign and malignant tumors . Distinct constituents of 
the extracellul ar matrix include collagens, proteoglycans, e lastic 
fibers, and noncollagenous glycoproteins [2] . Proteoglycans are 
m acromol ecules characterized by a pro te in COre and one o r more 
attached glycosaminoglycan chain s; both m oieties confer specific 
fun cti onal properties [2]. Biglyc3n (a lso named PG-I) ;U1d decorin 
(PG-Il) are two small proteoglycans with homologous core proteins 
of similar size (about 40 kD), which are Linked with two and one 
chondro itin / dermata n sul fate side chains, respectively [3,4]. PG-
100 is 3 recently described proteoglycan with a glycosylated core 
protein of about 100 kD, carryi ng m ost likely one chondroitin 
sulfate chain [5]. 
DecQl'in has been shown to be lo cated at the surface of type I 
co llagen fibri ls [6] and to inAu en ce co llagen fibrill ogen esis [7]. 
Decorin and biglycan exert 3n inhibi tory inAuen ce o n fibrobl ast 
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and PG-100 was absent or strongly down-regulated 
in the tumor tissue. Tumor cells thus displayed a 
staining pattern similar to that found on the basal 
cells of normal human skin. In the stroma sur-
rounding the tumor, however, the expression of 
biglycan and to a lesser degree decorin was in-
creased when conlpared with normal human der-
mis. The increased deposition appears to be due to 
an increased synthesis of these molecules, as total 
RNA extracted from basal cell carcinoma tissue 
revealed an induction of biglycan and decorin 
mRNA. This study indicates that the expression of 
proteoglycans in basal cell carcinoma tumor cells 
and in tumor stroma is altered from that in normal 
skin. Key lVof,ds: deco l'l llJbigiyca.n/skill. J Illvest Del'ma.to / 
104:509-513, 1995 
adhesion to different substrates [8,9] . It was also found that 
transfo rming growth facto r-{3 forms in active complexes with 
both proteoglycans [10], thereby affording these and other 
proteoglycans a role in th e modulation of growth-factor activi-
ties [11]. A unique physio logic role of biglycan and PG-l00, 
however, is not yet known, and li ttle is known about th e 
di stributio n of th ese m olecul es in adu lt human skin. 
Basal cell carcin oma (BCC) is the most common cutaneous 
tumor afl:ecting light-skinned people. Typically, BCC tumor masses 
are surrounded by dense strands of conn ective tissue stroma [12]. 
T he mechanisms that control this activation of connective tissue 
meta bolism around BCC is poorly understood . Because BCC 
tum ors rarely metastasize and culturing ofBCC cells often results in 
limited growth and frequent terminal differentiation , it had been 
suggested that the stroma in BCC provides important signals for 
tumor growth [1 2]. Proteoglycans. as structural components of the 
extracellular matrix with the capacity to modulate growth-factor 
activity [2,11 ], also may be involved in tile processes controlling 
BCC growth and connective tissue activation. In addition, proteo-
glycans as surface m olecul es m ay determine the degree and char-
acteristics of tumor cell invasion by affecting epidermal cell differ-
entiation . 
T he objective of th e present study was therefore to compare and 
define the patterns oflocalization of three sm all proteoglycans, i.e., 
biglycan , decorin. and PG-l00 , in norma l human skin and in basal 
cell carcinom a. 
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MATERIALS AND METHODS 
Tissue Samples Twelve cases of BCC were excised after obtaining 
informed consent. Normal skin was obtained from patients admitted for 
tattoo excisions from sun-exposed locations. Specimens were bisected; one 
half was used for routine paraffin processing for histologic classification (10 
solid, two superficial), whereas the other hal f was snap frozen in liquid 
nitrogen and stored at - 70°C until required. 
Immunohistochemical Staining Inrlirect immunoperoxidase staining 
was performed as described previously [13] using 3-amino-9-ethyl-carba-
zole (Sigma, St. Louis, MO) diluted in dimethylsulfoxide as the reagent. 
Alternatively, alkaline phosphatase anti-alkaline phosphatase staining was 
performed following es tablished procedures [1 4]. Rabbit anti-mouse im-
munoglobulins and alkaline phosphatase 'lI1ti-alkaline phosphatase com-
plexes were obtained from DAKO (Dakopatts, Hamburg, Germany) . T he 
alkaline phosphatase reaction was demonstrated by incubation in a solution 
containing Fast R ed RC (1 mg/ ml; Sigma) and naphtol AS-TR phosphate 
(0.2 mg/ ml; Sigma). Levamisole (0 .24 mg/ml) was added to block endo-
genous alkaline phosphatase activity. 
Antibodies R abbit antisera against human decorin, biglycan, and PG-100 
were those used previously [1 5,16]. For .affinity purification of the antisera, 
intact decorin and PG-100 as weB as the biglycan-derived peptide/albumin 
complex were allowed to react with cyanogen-bromide- activated Sepha-
rose (Sigma), as described by the manufacturer. Columns of these affinity 
matrices were loaded with antiserum at ambient temperature, foB owed by 
excessive washing with 20 111M sodium phosphate buffer, pH 7.4, contain-
ing 0.5 M NaCl. Specific antibodies were desorbed by applying 0.1 M 
glycine/HCl buffer, pH 2.5. Portions of the eluate were immediately 
neutralized with 1 M NaHCO, and then dialyzed against phosphate-
buffered saline. 
Controls Negative controls consisted of omi tting primary antibodies, 
using preimmune rabbit serum, and staining with the dye alone. As a 
positive control, we used a polyclonal antibody direc ted against keratin. In 
all cases, qualitatively identical staining patterns were observed regardless of 
whether a crude antiserum or affinity-purified antibodies derived therefrom 
was employed for immunohistochemistry. 
Northern Blot Analysis Frozen biopsy specimens were cut on dry ice 
and homogel~ized in 4 M guanidine-isothiocyanate containing 0.1 M 2-
mercaptoethanol. RNA was separated by ultracentrifugation over a cesium 
chloride cushion according to published protocols [17]. For Northern blot 
analysis, 10 p.g tota l RNA was separated by gel electrophoresis in 1 % 
agarose under denaturing conditions and then blotted onto a nylon mem-
brane (Genescreen, Dupont). Filters were hybrirlized according to pub-
lished protocols [17] with 32P-labe led nick-trans lated cDN A probes, using 
a 1.78-kilobase pair (kb) human cDNA for decorin [4,20], a 1 .69-kb human 
eDNA (P16) for biglycan (kindly supplied by Dr. L.A. Fisher) [3], and a 
1.3-kb cD NA for glyceraldehyde-3-phosphate dehydrogenase (kindly pro-
vided by Dr. J. Uitto) . After hybridization , the filters were washed and 
exposed at - 80°C to a radiosensitive fi lm. Before rehybridization , the filters 
were stripped in 0.1 X sodium citrate/sodium chloride buffer , 1% sodium 
dodecylsulfate for 20 min at 100°C. 
R ESULTS 
Twelve cases of BCC were investigated. Most tumors were re-
m oved from sun-exposed areas; 10 w e re BCC of th e solid type and 
only two were classified as superficial BCC. In normal human skin 
and in aU BCC specime ns, a distin ct pattem of staining was 
observed for aU three proteoglycans investigated (Table I), with n o 
major difFe ren ces occurring betw een th e difFerent hi stolog ic types. 
Staining with antibo dies against decorin/PG-ii revealed a posi-
tive reactio n throughout the connective tissue of the dermis, which 
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Table I. Expression of Decorin, Biglycan, and PG-100 in 




Basal Layer Supra basa l Layer Dermis Cells Stroma 
Decorin + + 
Biglycan + (+) + 
PG-I00 + + 
was most intense directly below the basement m embrane . No 
staining could b e detected in the epidermis. By using affinity-
purified antibodies to confirm the specificity of the staining, we 
observed a comparable staining of the d ermis , showing again the 
markedly increased expression of decorin b elow the base m ent 
m embrane (Fig 1a) . In BCC, the tumor cells and the epide rmis 
remained unstained. However, in aU biopsy specimens examined, 
the stroma surrounding the tumor islands showed a strong staining 
for decorin with a considerable increase in the direct vicinity of the 
tumor. The inten sity was similar as in normal human skin directly 
b elow the basement membrane (Fig 1b,c) . When total RNA from 
two specimens of BCC (Patients 3 and 10) was isolated and 
Northem blot analysis perfonned, the expression of decorin mRNA 
was increased when compared with nom1al skin (Patient 3, Fig 2). 
Biglycan/PG-I was d e tected in comple tely difFe rent cell popula-
tions. In normal human skin, staining for biglycan w as found in all 
suprabasallayers of the epidermis and as a narrow b and below the 
basem ent m embrane , whereas no staining was observed in the 
reticular d ermis (Fig 1tl) . In addition, som e staining could be seen 
in and around blood vessels and in the stroma surr~unding h air 
follicles (not shown) . All BCCs examined showed a markedly 
altered expression of big lycan/PG-1 when compared with normal 
skin . In the tumor cells ofBCC, a comple te or nearly comple te lack 
of biglycan expression was d e tected (Fig 1e,j). In tumors extending 
directly from the epidermis, tumor ceUs graduaUy lost this expres-
sion with the d epths of tumor invasion (not shown). In contrast , the 
cOlm ective tissue surrounding the tumor displayed p ositive staining 
for biglycan (Fig 1e,j), increasing in inte n sity directly below the 
b asem ent m e mbran e surrounding the BCC. Affinity-purified anti-
bodies d emonstrated a sii11ilar staining (Fig 1j). In perilesional skin 
o r epidermis overlying the tumor, the expression of big lycan was 
preserved (fig 1e) . After isolation of total RNA from BCC 
(patients 3 and 10) and Northern blo t analysis, a marked increase of 
biglycan mRNA expression was found in comparison to normal 
skin, indicatin g that the increased d eposition of big lycan is due to 
enhance d synthesis of tlus molecule (patient 3, Fig 2) . 
Figure 19 sh ows the immunohistoch emical expression in n o rmal 
human skin of the tlurd smaU proteoglycan (PG-100) investigated. 
PG-100 could b e found in all laye rs of the epidernlis , altho ugh in 
som e sp ecil11ens its expression in the b asal layer, was diminished, 
partic u la rly in areas containing m elanocytes. T h e connective tissue 
of the de nnis showed no staining for PG-l00, whereas eccrine 
sweat ducts and smooth-muscle cells de monstra te d a positive sign al 
(Fig 111). Similar staining was o btained u sin g afrtnity-purifled 
antibo dies, confirmi11g the spetificity of the staining (Fig 19). In all 
Figure 1. Detection of dccorin, biglycall, and PG-100 in normal human Skill and BCC. Detection of decorin (a ,b,c), biglycan (d,eJ), and PG-IOO 
VI,h,I) iJ1 nonnal skin (a,d,g, I, ) and BCC (b ,e,eJ, l) using peroxid<l se staining (b, e, d,e,,) or alkaline phosphatase anti-a lkaline phosphatase sta ining (tIJ,g,II) when 
affinity-purified antibodies were used. n) Note the incre<lsc in staining intensity for decorin (arroJ/lh eads) directly below the basement membrane. Bar, 100 p.m) . 
I" c) In BCC, there is a lack of expression in tumor cells and a strong sig"'ll in the stroma surrounding the tumor cells . Bars: b, 200 p.m; c, 50 p.m. d) Uiglycan 
iJ1 normal skin can be detected in suprabasal layers and directly below the basement membrane (a fl·oJ/lI, eads) . Endothelial cells al so express biglycan (arroJ/l). 
Bar, 200 p.m. eJ) In BCC, note the complete lack of expression in tumor cells (al1"owllends); the expression in the stroma surrounding the tumor and the 
staining in the epidenl1is overlaying the tumor (e) are comparable to the staining in normal skin. Bars: e, 100 p.m ; .f; 50 p.m . g) PG-IOO can be detected 
throughout all layers of the epidermis. Bar, 100 p.m . II) PG- IOO is also fo und in smooth-muscle ceBs, whereas no expression is found il1 the dermis or <ll ong 
the basement membrane. Bar, 50 p.m. I) In BCC, there is a lack of expression in the tumor island (an'o",heads), whereas the epidermis overl <lying the BCC 
shows an expression pattern comparab le to 110rmal human skin. Bar, 200 p.m . 
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Figure 2. Decorin and biglycan mRNA are increased in BCC 
tissue. Ten micrograms of total RNA was extracted from healthy donor 
skin (Ialle 1) or from Bee tissue (patie'nt 3) (Iall e 2). The membrane was 
probed for mRNA expression of (A) decorin (2.3 kb), stripped, and probed 
for (B) biglycan (3.2 kb). Hybridization with glyceraldehyde-3-phosphate 
dehydrogenase was used as a control (q . Sca.nning of the Northern blot and 
normalization to glyceraldehyde-3-phosphate dehydrogenase revealed a 
2.4-fold induction for decorin and a 4.7-fold induction for biglycan. 
BCC specimens studied, absent or only marginal expression of 
PG-I00 couJd be detected in or around tumor cells (Fig Ii). In 
contrast to the expression pattern found for biglycan or decorin, 
PG-I00 was not deposited in the tumor stroma. 
DISCUSSION 
Using polyclonal antibodies against the core proteins of three small 
proteoglycans, we demonstrated that in normal human skin the 
staining pattern of decorin and biglycan, two closely related 
molecules, and of the recently described PG-I00 [5] is markedly 
distinct. This characteristic pattern is altered in a specific fashion in 
BCC. Our results confirm that in normal human skin, the immu-
nocytochemical expression of decorin is restricted to the dermis, 
which is in agreement with previous studies in fetal and adult 
human skin [18,19]. In addition, we fowld that in adult human skin, 
a stronger staining for decorin can be detected directly below the 
basement membrane. TillS finding is complementary to results 
obtained by Schi.inherr et al [20] describing an increased expression 
of decorin in fibroblasts of the papillary dermis when compared 
with fibroblasts obtained from the reticular dermal layer. An 
increased level of decorin expression was also detected in the 
cOlmective tissue surrounding the tumor cells of BCC when 
compared with uninvolved periJesional skin. This finding is in line 
wiili recent studies showing an increased level of decorin expres-
sion around human colon carcinoma, where these changes were 
also associated with an altered structure of the attached glycosami-
noglycan chains [21]. However, these changes in connective tissue 
composition were found to be absent in malignant neoplasms that 
do not induce a stromal response [22,23) , supporting the specificity 
of this finding. 
Biglycan, which is closely related to decorin 'in terms of amino 
acid sequences [3), differs in its expression by different cell types 
[24], its regulation by cytokines [25], and its physicochemical 
properties [26]. Our study demonstrates that in contrast to decorin, 
biglycan is mainly expressed in supra basal layers of the epidermis; 
this finding extends previous observations on fetal skin [20) to the 
adult tissue. We show additionally that in adult human skin, 
biglycan is also expressed in a narrow band below the basement 
membrane. T illS is in line with ;/1 vitro studies showing that kera-
tinocytes may synthesize this molecule (unpublished observation), 
whereas skin fibroblasts express small amounts of biglycan in 
comparison with decorul [26]. In all BCCs studied, absent or little 
expression was found in the tumor cells, but a markedly increased 
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deposition ofbiglycan was found below the basement membrane of 
the tumor, decreasing in intensity to the periphery of the surround-
ing cOlmective tissue . The increased deposition Ul the cOlmective 
tissue appears to be due to an increased de /l OVO synthesis, as shown 
by the marked induction of biglycan mRNA levels found in total 
RNA obtained from BCe. 
The expression of PG-I00, a protein originally described in a 
human osteosarcoma cell line [5), could be localized to all layers of 
the epidermis in normal human skin, whereas absent or extremely 
little expression was detected in the connective tissue of the dermis 
or the stroma of BCC. In contrast to biglycan , expression of 
PG-l00 was preserved in follicular cells . The tumor cells of BCC 
displayed little or no expression ofPG-100. Together with the lack 
ofbiglycan expression in the basal cell layer of nomlal skin, tillS loss 
of immunocytochemical expression of biglycan and PG-I00 in the 
tumor cells ofBCC suggests that these proteoglycans are important 
for the regulation of cell growth and maultenance of nonnal tissue 
architecture. Our study descl;bes an increase of decorul and 
biglycan expression in the stroma ofBCC, a result that differs from 
the recently found increase of biglycan but decrease in decorin 
expression in bleomycin-induced fibrosis [27] . However, these 
differences of small proteoglycan expression found in BCC and Ul 
experimentally induced fibros is could mean that the activation of 
cOl1l1ective tissue m etabolism Ul the vicinity of a tumor or an 
inflammatory fibrotic process is differently regulated. 
This study indicates that an altered expression of proteoglycans in 
BCC tumor cells and tumor stroma may resu lt in an altered bindmg 
and activation pattern of growth factors as well as an altered 
migration and attachment of ceLIs, and may thus have an important 
role in deternlullng growth and progression of the tumor itself. 
TI,;s IIIork IIIaS SIIfJfJorted I!y lite Delltsclte ForscllIlIIgsgelllcillscltaji (SFB 310, Project 
B2) alld tlte BMFT (Ver/J11l1dprojekt "LYlllpltokille"). 
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